Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc. > Buyout framework
View:
Post by NamesJeb on Oct 24, 2020 8:54am

Buyout framework

I was wondering if anyone here has much experience with what exactly the process would be if Ifenprodil does reach statistical significance and companies started making offers? What exactly would happen to share structure? Would it be a buyout, or partnership, and would the other ipf/chronic cough trial be effected from a shareholder perspective?
Comment by TheBearInTheWoods on Oct 25, 2020 11:54pm
Without a patent pharma wouldn't waster their time, enjoy 
Comment by Proinvest2020 on Oct 26, 2020 6:27am
Bear in woods, Haven't they clearly stated that they have the intellectual property rights for ifenprodil's use for respiratory issues?    if they don't why would they say so? Why would they spend all this time and effort to run these trials?   
Comment by TheBearInTheWoods on Oct 26, 2020 9:17am
Algernon has filed new intellectual property rights globally for NP-120 (ifenprodil) for the treatment of respiratory diseases and is working to develop a proprietary injectable and slow-release formulation. the drug is from the 1970s, it must be a method of use patent. Very weak and not awarded yet, I hope you make money but don't expect a big pharma buyout from a 5 year old drug and no ...more  
Comment by Proinvest2020 on Oct 26, 2020 9:21am
Ahh ok... so filed for the rights... guess i heard what I wanted to hear.  Not sure if there would be a reason to not grant the right to use it for resp. illness. Thats a big if ... Worth the risk for me if the drug works as expected. Not so Pro I guess..lol!
Comment by Triggertwo on Oct 26, 2020 9:58am
BITW you obviously don't know what your talking about. I will ignore you in the future. [Prominent examples include Pfizer’s Viagra (sildenafil) for erectile dysfunction and Celgene’s Thalomid (thalidomide) for the treatment of erythema nodosum leprosum (ENL) and multiple myeloma.] https://www.biopharma-excellence.com/news/2019/2/25/drug-repurposing-how-to-protect-your-asset-by-an-integrated ...more  
Comment by TheBearInTheWoods on Oct 26, 2020 10:20am
The drug is already being manufactured and sold, has been since the 1979s. If there is success I would imagine mild success for AGN and huge success for the pharma companies already manufacturing the drug.
Comment by Pandora on Oct 26, 2020 10:33am
Yes, you can purchase it relatively cheap in Japan right now.
Comment by NamesJeb on Oct 26, 2020 12:01pm
Yes you can "legally?" purchase Ifenprodil from Japan if you're suffering from dizziness right now. Algernon Pharmaceuticals is now 1st in line to own the rights to Ifenprodil to treat Covid-19, IPF and Chronic cough however. From my understanding this means if proven successful these Japanese and whatever other companies that are currently manufacturing it can't just suddenly ...more  
Comment by NamesJeb on Oct 26, 2020 12:04pm
Also patents expire after 20 years(give or take a year or so extension) Ifenprodil patent is long expired I believe.
Comment by Raddnar on Oct 26, 2020 1:24pm
Your ignorance on how the FDA and other countries’ version of it work is outstanding. Instead of posting you should read.
Comment by NamesJeb on Oct 26, 2020 10:18am
Well I must start by thanking you for not answering my question regarding how the buyout process works whatsoever. However I just did some quick research regarding patents and their timeframe. Looks like a patent can take anywhere from 1(expedited)-3 years for approval. "While your patent application is pending (after the patent application is filed but before the patent is granted) you will ...more  
Comment by Raddnar on Oct 26, 2020 1:28pm
Don’t feed the bear. AGN is covered for ifenprodil. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse